Report cover image

Global Companion Animal Specialty Drugs Market 2025-2029

Publisher TechNavio
Published Mar 01, 2025
Length 237 Pages
SKU # INF19750031

Description

Companion Animal Specialty Drugs Market 2025-2029

The companion animal specialty drugs market is forecasted to grow by USD 6541.2 million during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization, rising awareness about disease prevention and pet insurance, and rise in aging companion animal population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's companion animal specialty drugs market is segmented as below:

By Distribution Channel
  • Veterinary hospitals
  • Pet care clinics
  • Pharmacy stores
By Product
  • Vaccines
  • Antibiotics
  • Parasiticides
  • Feed additives
  • Others
By Route Of Administration
  • Oral
  • Injectable
By Animal Type
  • Cats
  • Dogs
  • Horses
  • Others
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the enhanced companion animal specialty drug offerings as one of the prime reasons driving the companion animal specialty drugs market growth during the next few years. Also, increase in merger and acquisition in animal companion specialty drugs market and rising obesity in companion animals will lead to sizable demand in the market.

The report on the companion animal specialty drugs market covers the following areas:
  • Companion Animal Specialty Drugs Market sizing
  • Companion Animal Specialty Drugs Market forecast
  • Companion Animal Specialty Drugs Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion animal specialty drugs market vendors that include Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Orion Corp., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., and Zoetis Inc.. Also, the companion animal specialty drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

237 Pages
    • Market overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Criticality of inputs and Factors of differentiation
    • Factors of disruption
    • Impact of drivers and challenges
    • Market ecosystem
    • Market characteristics
    • Value chain analysis
    • Market definition
    • Market segment analysis
    • Market size 2024
    • Market outlook: Forecast for 2024-2029
    • Global Companion Animal Specialty Drugs Market 2019 - 2023
    • Distribution Channel segment analysis 2019 - 2023
    • Product segment analysis 2019 - 2023
    • Route of Administration segment analysis 2019 - 2023
    • Animal Type segment analysis 2019 - 2023
    • Geography segment analysis 2019 - 2023
    • Country segment analysis 2019 - 2023
    • Impact of AI on Companion Animal Specialty Drugs Market
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Distribution Channel
    • Veterinary hospitals - Market size and forecast 2024-2029
    • Pet care clinics - Market size and forecast 2024-2029
    • Pharmacy stores - Market size and forecast 2024-2029
    • Market opportunity by Distribution Channel
    • Market segments
    • Comparison by Product
    • Vaccines - Market size and forecast 2024-2029
    • Antibiotics - Market size and forecast 2024-2029
    • Parasiticides - Market size and forecast 2024-2029
    • Feed additives - Market size and forecast 2024-2029
    • Others - Market size and forecast 2024-2029
    • Market opportunity by Product
    • Market segments
    • Comparison by Route of Administration
    • Oral - Market size and forecast 2024-2029
    • Injectable - Market size and forecast 2024-2029
    • Market opportunity by Route of Administration
    • Market segments
    • Comparison by Animal Type
    • Cats - Market size and forecast 2024-2029
    • Dogs - Market size and forecast 2024-2029
    • Horses - Market size and forecast 2024-2029
    • Others - Market size and forecast 2024-2029
    • Market opportunity by Animal Type
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2024-2029
    • Europe - Market size and forecast 2024-2029
    • Asia - Market size and forecast 2024-2029
    • Rest of World (ROW) - Market size and forecast 2024-2029
    • US - Market size and forecast 2024-2029
    • Germany - Market size and forecast 2024-2029
    • China - Market size and forecast 2024-2029
    • Canada - Market size and forecast 2024-2029
    • France - Market size and forecast 2024-2029
    • Japan - Market size and forecast 2024-2029
    • UK - Market size and forecast 2024-2029
    • India - Market size and forecast 2024-2029
    • South Korea - Market size and forecast 2024-2029
    • Italy - Market size and forecast 2024-2029
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market opportunities/restraints
    • Overview
    • Competitive Landscape
    • Landscape disruption
    • Industry risks
    • Companies profiled
    • Company ranking index
    • Market positioning of companies
    • Bayer AG
    • Beaphar Beheer BV
    • Bimeda Holdings Ltd.
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals Plc
    • Elanco Animal Health Inc.
    • LABORATORIOS CALIER S.A
    • Mars Inc.
    • Merck and Co. Inc.
    • Neogen Corp.
    • Norbrook Laboratories Ltd.
    • Vetoquinol SA
    • Virbac Group
    • Zoetis Inc.
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • Data procurement
    • Data validation
    • Validation techniques employed for market sizing
    • Data synthesis
    • 360 degree market analysis
    • List of abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us